Bill Texts: NJ AR30 | 2016-2017 | Regular Session

Bill Title: Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.

Sponsorship: Partisan Bill (Democrat 2)

Status: (Passed) 2017-02-15 - Filed with Secretary of State [AR30 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2016-01-27HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey AR30

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey AR30 currently on file.

feedback